Your browser doesn't support javascript.
loading
Evaluation of clinical findings and neurofibromatosis type 1 bright objects on brain magnetic resonance images of 60 Turkish patients with NF1 gene variants.
Hazan, Filiz; Gürsoy, Semra; Unalp, Aycan; Yilmaz, Unsal; Demirag, Bengü; Aydin Köker, Sultan; Ozyilmaz, Berk; Erdogan, Kadri Murat; Kalenderer, Önder; Erkus, Serkan; Gürçinar, Müge; Tükün, Ajlan.
Afiliação
  • Hazan F; Department of Medical Genetics, Dr. Behcet Uz Children's Hospital, Izmir, Turkey.
  • Gürsoy S; Department of Pediatric Genetics, Dr. Behcet Uz Children's Hospital, Izmir, Turkey.
  • Unalp A; Department of Pediatric Neurology, Dr. Behcet Uz Children's Hospital, Izmir, Turkey.
  • Yilmaz U; Department of Pediatric Neurology, Dr. Behcet Uz Children's Hospital, Izmir, Turkey.
  • Demirag B; Department of Pediatric Hematology and Oncology, Dr. Behcet Uz Children's Hospital, Izmir, Turkey.
  • Aydin Köker S; Department of Pediatric Hematology and Oncology, Dr. Behcet Uz Children's Hospital, Izmir, Turkey. drsultanaydin@hotmail.com.
  • Ozyilmaz B; Department of Medical Genetics, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Erdogan KM; Department of Medical Genetics, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Kalenderer Ö; Department of Orthopaedics and Traumatology, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Erkus S; Department of Orthopaedics and Traumatology, Tepecik Training and Research Hospital, Izmir, Turkey.
  • Gürçinar M; Department of Radiology, Alsancak Imaging Center, Izmir, Turkey.
  • Tükün A; Division of Medical Genetics, Duzen Laboratories Group, Ankara, Turkey.
Neurol Sci ; 42(5): 2045-2057, 2021 May.
Article em En | MEDLINE | ID: mdl-33443663
ABSTRACT
Neurofibromatosis type 1 (NF1) is caused by mutations in the NF1 gene. This retrospective study aims to evaluate the clinical manifestations and brain magnetic resonance images (MRI) analysis in 60 genetically confirmed NF1 patients. The results of next-generation sequencing (NGS), Sanger sequencing, and MLPA of NF1 gene were evaluated. A total of 54 different variants were identified. Fourteen out of them were novel variants (25.9%). Patients who complied with NIH criteria had most frequently frameshift variants (11/32 patients), and those with only CALMs had missense variants (9/28 patients). Neurofibromatosis type 1 bright objects (NBOs) on T2-weighted MRI were detected in 42 patients (42/56; 75%). These brain lesions were detected mostly in basal ganglia and in cerebellar vermis. NBOs were detected more in the patients who complied with NIH criteria (80.6%) compared to those who were only CALMs (68%). While frameshift variants (33.3%) were the most common type variants in the patients who had NBOs, the most common variants were splicing (35.7%) and missense (35.7%) variants in the patients whose MRIs were normal. Frameshift variants (11/28 patients; 39.3%) were the most common in the patients with more than one brain locus involvement. Therefore, we consider that frameshift variants may be associated with increased incidence of NBOs and involvement of more than one brain locus. In addition, NBOs may occur less frequently in the patients with splicing variants. To our knowledge, this is the first study evaluated the relationship between NF1 gene variants and NBOs. Future studies may help us understand the etiology of NBOs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article